Hobbs Rod S, Fletcher Garth L
Ocean Sciences Centre, Memorial University of Newfoundland, A1C 5S7, St. John's, NL, Canada.
Transgenic Res. 2008 Feb;17(1):33-45. doi: 10.1007/s11248-007-9128-5. Epub 2007 Sep 2.
Previous research aimed at producing genetically improved salmon broodstock for aquaculture led to the creation of two lines of transgenic Atlantic salmon using gene constructs that were derived in part from the ocean pout OP5a antifreeze protein (AFP) gene. One of the lines was produced using an OP5a AFP gene in which the 5' region of the promoter was removed (termed t-OP5a-AFP), and the other line contains a growth hormone (GH) transgene (EO-1alpha) that consists of a chinook salmon GH cDNA driven by a truncated OP5a AFP promoter that is almost identical to that of the t-OP5a-AFP construct. The similarity of the promoter regions of these transgenes provided an opportunity to evaluate their tissue specific expression patterns. Expression of mRNA was evaluated using Northern blot and RT-PCR techniques. The results demonstrate that the AFP and GH trangenes were expressed in almost all body tissues, suggesting that the promoter region of the OP5a AFP gene lacks tissue specific elements. Northern analysis revealed that expression of the t-OP5a-AFP gene was considerably greater than that of the EO-1alpha GH transgene. Only the spleen tissue of the GH transgenics showed a visible band of hybridization. In contrast clear bands of hybridization were evident in all tissues, except for blood cells, of the AFP transgenics with heart, liver and brain tissue showing the highest levels of mRNA expression. This higher level of expression could be attributable to the presence of introns in the t-OP5a-AFP transgene. Since the GH transgenic salmon grow considerably faster than non-transgenics the low levels of GH transgene expression in this line were clearly sufficient to produce the desired rapid growth phenotype. In contrast the levels of AFP expression were inadequate to impart any improvement in the freeze resistance of the AFP transgenic salmon.
先前旨在培育用于水产养殖的基因改良鲑鱼亲鱼的研究,导致使用部分源自海洋大头鱼OP5a抗冻蛋白(AFP)基因的基因构建体,创建了两个转基因大西洋鲑鱼品系。其中一个品系是使用去除了启动子5'区域的OP5a AFP基因(称为t-OP5a-AFP)培育而成,另一个品系包含一个生长激素(GH)转基因(EO-1alpha),该转基因由奇努克鲑鱼GH cDNA组成,由一个几乎与t-OP5a-AFP构建体的启动子相同的截短的OP5a AFP启动子驱动。这些转基因启动子区域的相似性为评估它们的组织特异性表达模式提供了机会。使用Northern印迹和RT-PCR技术评估mRNA的表达。结果表明,AFP和GH转基因在几乎所有身体组织中均有表达,这表明OP5a AFP基因的启动子区域缺乏组织特异性元件。Northern分析显示,t-OP5a-AFP基因的表达明显高于EO-1alpha GH转基因。只有GH转基因鱼的脾脏组织显示出可见的杂交带。相比之下,AFP转基因鱼的所有组织(血细胞除外)均有明显的杂交清晰条带,心脏、肝脏和脑组织的mRNA表达水平最高。这种较高的表达水平可能归因于t-OP5a-AFP转基因中内含子的存在。由于GH转基因鲑鱼的生长速度明显快于非转基因鲑鱼,因此该品系中GH转基因的低表达水平显然足以产生所需的快速生长表型。相比之下,AFP的表达水平不足以提高AFP转基因鲑鱼的抗冻性。